Concurrent chemoradiotherapy for patients with inoperable esophageal cancer
- VernacularTitle:同步放化疗治疗不能手术的食管癌临床结果
- Author:
Jun LIU
;
Changxing LU
;
Jiaming WANG
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasmas/radiotherapy;
Esophageal neoplasmas/chemotherapy;
Prognosis
- From:
Chinese Journal of Radiation Oncology
1993;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective Objective To evaluate the response,survival and toxicity of concurrent chemoradiotherapy for patients with inoperable esophageal cancer. Methods Eighty-eight patients with inoperable esophageal cancer were divided randomly into two groups, 43 patients in group R+C received chemoradiotherapy, while 45 patients in group R received radiotherapy only. For both groups, the same radiation technic was carried out by conventional fractionation, to a total dose of 60-65Gy/30-33Fr/6.0-6.5W. For group R+C patients, concurrent chemotherapy(5-Fu 500mg/d1-4,DDP 20mg/d1-4) was given. Results Complete response rate in group R+C was 33%,while in group R, it was 13% (P
